Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-008510

SVP, Head of Global Commercial acquired 12,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Porter Derrell SVP, Head of Global Commercial 2018-02-06 Grant or award +12,500 14,044 D
Derivatives
Porter Derrell SVP, Head of Global Commercial 2018-02-06 Grant or award · Employee Stock Option (Right to Buy) +25,000 25,000 D
Loading xslF345X03/doc4.xml…